Eric D. Donnenfeld, MD, is a paid consultant for ISTA Pharmaceuticals, Inc., and was a principal investigator in the US Phase III bromfenac clinical trials. Dr. Donnenfeld is also a paid consultant for Allergan, Inc., and Alcon Laboratories, Inc.
No takes yet. Share an insight, caveat, or question.
Donnenfeld et al. (2006) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: